Group 1 - The company has announced the list of participants for its 2025 stock option incentive plan, which was approved by the board and supervisory committee [1][4] - The internal announcement regarding the incentive plan was made from August 29 to September 7, 2025, with no objections received during this period [2][1] - The compensation committee verified the eligibility of the incentive plan participants, confirming they meet the necessary legal and regulatory requirements [3][5] Group 2 - The company has initiated a share repurchase program, with a total repurchase amount set between RMB 100 million and RMB 200 million, and a maximum repurchase price of RMB 25.70 per share [7][9] - As of September 8, 2025, the company has repurchased 8.1079 million shares, representing 2.04% of the total share capital, with a total expenditure of approximately RMB 148.4649 million [9][10] - The company will continue to comply with relevant regulations during the share repurchase process and will disclose updates as necessary [11] Group 3 - The company will hold its second extraordinary general meeting of 2025 on September 15, 2025, utilizing both on-site and online voting methods [13][14] - The meeting will address several proposals that have already been approved by the board and supervisory committee [19][20] - Shareholders must register in advance to attend the meeting, with specific guidelines provided for both on-site and written registration [29][30]
广西柳药集团股份有限公司董事会薪酬与考核委员会关于公司2025年股票期权激励计划激励对象名单的公示情况说明及核查意见